258 related articles for article (PubMed ID: 15544624)
1. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.
Lai KN; Leung JC; Chan LY; Li FF; Tang SC; Lam MF; Tse KC; Yip TP; Chan TM; Wieslander A; Vlassara H
Clin Exp Immunol; 2004 Dec; 138(3):466-75. PubMed ID: 15544624
[TBL] [Abstract][Full Text] [Related]
2. Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF.
Leung JC; Chan LY; Li FF; Tang SC; Chan KW; Chan TM; Lam MF; Wieslander A; Lai KN
Nephrol Dial Transplant; 2005 Jul; 20(7):1336-49. PubMed ID: 15814533
[TBL] [Abstract][Full Text] [Related]
3. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL
Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
[TBL] [Abstract][Full Text] [Related]
4. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
Schwenger V; Morath C; Salava A; Amann K; Seregin Y; Deppisch R; Ritz E; Bierhaus A; Nawroth PP; Zeier M
J Am Soc Nephrol; 2006 Jan; 17(1):199-207. PubMed ID: 16319192
[TBL] [Abstract][Full Text] [Related]
5. Antiglycation and antioxidant effect of carnosine against glucose degradation products in peritoneal mesothelial cells.
Alhamdani MS; Al-Kassir AH; Abbas FK; Jaleel NA; Al-Taee MF
Nephron Clin Pract; 2007; 107(1):c26-34. PubMed ID: 17664891
[TBL] [Abstract][Full Text] [Related]
6. Glucose degradation products and peritoneal membrane function.
Witowski J; Bender TO; Gahl GM; Frei U; Jörres A
Perit Dial Int; 2001; 21(2):201-5. PubMed ID: 11330569
[TBL] [Abstract][Full Text] [Related]
7. Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids.
Yamamoto T; Tomo T; Okabe E; Namoto S; Suzuki K; Hirao Y
Nephrol Dial Transplant; 2009 May; 24(5):1436-42. PubMed ID: 19033251
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
[TBL] [Abstract][Full Text] [Related]
9. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
10. Effect of glucose degradation products on human peritoneal mesothelial cell function.
Witowski J; Korybalska K; Wisniewska J; Breborowicz A; Gahl GM; Frei U; Passlick-Deetjen J; Jörres A
J Am Soc Nephrol; 2000 Apr; 11(4):729-739. PubMed ID: 10752532
[TBL] [Abstract][Full Text] [Related]
11. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
[TBL] [Abstract][Full Text] [Related]
12. Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.
Witowski J; Bender TO; Wisniewska-Elnur J; Ksiazek K; Passlick-Deetjen J; Breborowicz A; Jörres A
Perit Dial Int; 2003; 23(4):381-90. PubMed ID: 12968847
[TBL] [Abstract][Full Text] [Related]
13. Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.
Tomo T; Okabe E; Yamamoto T; Namoto S; Iwashita T; Matsuyama K; Kadota J
J Artif Organs; 2007; 10(1):47-51. PubMed ID: 17380297
[TBL] [Abstract][Full Text] [Related]
14. Increased survival of mesothelial cells from the peritoneum in peritoneal dialysis fluid.
Lai KN; Ho SK; Leung J; Tang SC; Chan TM; Li FK
Cell Biol Int; 2001; 25(5):445-50. PubMed ID: 11401332
[TBL] [Abstract][Full Text] [Related]
15. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
Boulanger E; Wautier MP; Wautier JL; Boval B; Panis Y; Wernert N; Danze PM; Dequiedt P
Kidney Int; 2002 Jan; 61(1):148-56. PubMed ID: 11786095
[TBL] [Abstract][Full Text] [Related]
16. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
17. Human RAGE antibody protects against AGE-mediated podocyte dysfunction.
Müller-Krebs S; Kihm LP; Madhusudhan T; Isermann B; Reiser J; Zeier M; Schwenger V
Nephrol Dial Transplant; 2012 Aug; 27(8):3129-36. PubMed ID: 22510380
[TBL] [Abstract][Full Text] [Related]
18. L-2-oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products.
Breborowicz A; Witowski J; Polubinska A; Pyda M; Oreopoulos D
Nephrol Dial Transplant; 2004 Dec; 19(12):3005-11. PubMed ID: 15507476
[TBL] [Abstract][Full Text] [Related]
19. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
[TBL] [Abstract][Full Text] [Related]
20. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
